The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
The efficacy of Bifidobacterium quadruple viable tablet in the treatment of the predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled multicenter trial.